News

The free webinar, "Derm Clinical Updates: Keeping Up with COVID-19," will feature a four-expert panel fielding topics on therapies, immunocompromised patients, telemedicine, surgery, and more.

New research from a hospital in Wuhan has found no difference in hypertension patients whether or not they were taking ACEi/ARBs on admission.

New research from an NIH-funded study suggest 0.004 mg bevacizumab could be an effective treatment for type 1 retinopathy of prematurity.

ABG-023 overcomes the limitations glucagon because it remains stable in solutions.

Infant separation anxiety moderated treatment efficacy with greater benefits to infants where parental presence is maintained.

Women are more likely to enter remission from cannabis dependency than men.

Analysis of more than 500k Norwegians has found filtered coffee might reduce risk of death and cardiovascular disease, while unfiltered coffee increased risk in older men.

Discussing recent data from GALACTIC-HF with John Teerlink, MD, Executive Committee Chair for both GALACTIC-HF and COSMIC-HF.

Policy reform is needed to give patients access to medications to treat their opioid use disorder.

The most common reason IBS patients discontinue treatment is a loss of prescription drug coverage.

California is home of the cities with the most unhealthy pollution levels, according to the newest annual report from the ALA.

New research from Weill Cornell Medicine is revealing more about the impact of social determinants on 90-day mortality following heart failure hospitalization.

New analysis of nationwide mortality statistics from the CDC is shedding light on an alarming trend among women in rural areas across the US.

This marks ibrutinib's 11th FDA approval.

New study finds fatigue is linked to the overall level of disability following a severe traumatic brain injury.

Discussing the impact of COVID-19 on clinical trials that are ongoing or in development with John Teerlink, MD, Executive Committee Chair of GALACTIC-HF.

Investigators find link between childhood psychopathology and polygenetic scores in a number of disorders, but not bipolar disorder.

Digital technologies may have the best opportunity to change how trials are conducted for years to come.

An analysis of 60,000-plus patients over 2 decades suggests consumption of olive oil could help reduce rate of CVD.

Numeric rating scales are more subjective than answering whether the pain is tolerable or not.

A fourth-year medical student writes about the use of CT for diagnosing COVID-19.

Only 20.2% of primary care physicians show interest in treating patients with opioid use disorder.

Worker productivity also increased from brief behavioral therapy for insomnia through a smartphone application.

Investigators assessing the link from CO to pneumonia risk—and the benefit of biomass-fueled cookstoves in reducing them—find it is not very distinct.

Patients too frequently self-assess their pneumonia risk, therefore reducing the efficacy of preventive measures.

A discussion on how COVID-19 has changed the role of cardiologists and the use of telehealth in clinical practice.

Dr. David Rubin discusses what IBD patients can do if they are asked to stop immunosuppressant treatment because of COVID-19.

New research suggests the presence of a maternal hypertensive disorder predicts increased risk of childhood mental disorder, regardless of mental disorder status of the parents.